Close
4

Quotient Sciences Quotient Sciences

X

Company profile for Qlaris Bio

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Qlaris Bio is a clinical stage biotechnology company founded with a singular focus: to develop novel, innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio's lead program is QLS-101, a novel compound invented at Mayo Clinic and the University of Minnesota. With QLS-101, we are targeting a key, unaddressed component of intraocular pressure (IOP), Episcleral Venous Pressure (EVP) and outflow dista...
Qlaris Bio is a clinical stage biotechnology company founded with a singular focus: to develop novel, innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio's lead program is QLS-101, a novel compound invented at Mayo Clinic and the University of Minnesota. With QLS-101, we are targeting a key, unaddressed component of intraocular pressure (IOP), Episcleral Venous Pressure (EVP) and outflow distal to the Trabecular Meshwork, that remain wholly unaddressed today. In addition to its potential use alone or as an additive therapy in Primary Open Angle Glaucoma or in Ocular Hypertension

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Qlaris Bio
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
55 William Street, Suite 250, Wellesley, MA 02481
Telephone
Telephone
(781) 943-3519
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY